PMID- 25810263
OWN - NLM
STAT- MEDLINE
DCOM- 20150911
LR  - 20240103
IS  - 1545-5017 (Electronic)
IS  - 1545-5009 (Print)
IS  - 1545-5009 (Linking)
VI  - 62
IP  - 8
DP  - 2015 Aug
TI  - SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations 
      for neuroblastoma in low- and middle-income settings.
PG  - 1305-16
LID - 10.1002/pbc.25501 [doi]
AB  - Neuroblastoma is the most common extracranial solid tumor in childhood in 
      high-income countries (HIC), where consistent treatment approaches based on 
      clinical and tumor biological risk stratification have steadily improved 
      outcomes. However, in low- and middle- income countries (LMIC), suboptimal 
      diagnosis, risk stratification, and treatment may occur due to limited resources 
      and unavailable infrastructure. The clinical practice guidelines outlined in this 
      manuscript are based on current published evidence and expert opinions. Standard 
      risk stratification and treatment explicitly adapted to graduated resource 
      settings can improve outcomes for children with neuroblastoma by reducing 
      preventable toxic death and relapse.
CI  - (c) 2015 The Authors. Pediatric Blood & Cancer, published by Wiley Periodicals, 
      Inc.
FAU - Parikh, Nehal S
AU  - Parikh NS
AD  - Department of Pediatrics, Division of Hematology-Oncology, Connecticut Children's 
      Medical Center, Hartford, Connecticut.
FAU - Howard, Scott C
AU  - Howard SC
AD  - University of Memphis, Memphis, Tennessee.
FAU - Chantada, Guillermo
AU  - Chantada G
AD  - Department of Hemato-oncology, Hospital JP Garrahan, Buenos Aires, Argentina.
FAU - Israels, Trijn
AU  - Israels T
AD  - VU University Medical Center, Amsterdam, the Netherlands.
FAU - Khattab, Mohammed
AU  - Khattab M
AD  - Department of Paediatrics, Children's Hospital of Rabat, Rabat, Morocco.
FAU - Alcasabas, Patricia
AU  - Alcasabas P
AD  - University of the Philippines-Philippine General Hospital, Manila, Philippines.
FAU - Lam, Catherine G
AU  - Lam CG
AD  - Department of Oncology and International Outreach Program, St. Jude Children's 
      Research Hospital, Memphis, Tennessee.
FAU - Faulkner, Lawrence
AU  - Faulkner L
AD  - Cure2Children Foundation, Florence, Italy.
FAU - Park, Julie R
AU  - Park JR
AD  - Seattle Children's Hospital, University of Washington School of Medicine and Fred 
      Hutchinson Cancer Research Center, Seattle, Washington.
FAU - London, Wendy B
AU  - London WB
AD  - Harvard Medical School, Boston Children's Hospital and Dana Farber Cancer 
      Institute, Boston, Maryland.
FAU - Matthay, Katherine K
AU  - Matthay KK
AD  - Department of Pediatrics, UCSF School of Medicine and UCSF Benioff Children's 
      Hospital, San Francisco, California.
CN  - International Society of Pediatric Oncology
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
PT  - Research Support, Non-U.S. Gov't
DEP - 20150321
PL  - United States
TA  - Pediatr Blood Cancer
JT  - Pediatric blood & cancer
JID - 101186624
SB  - IM
MH  - *Developing Countries
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Neoplasm Recurrence, Local/diagnostic imaging/*mortality
MH  - Neoplasm Staging
MH  - Neuroblastoma/*diagnosis/diagnostic imaging/*drug therapy
MH  - Poverty
MH  - Radiography
MH  - Radionuclide Imaging
MH  - Risk
MH  - Socioeconomic Factors
PMC - PMC5132052
OTO - NOTNLM
OT  - MYCN
OT  - Neuroblastoma
OT  - diagnosis
OT  - low income countries
OT  - resource limited countries
OT  - treatment
EDAT- 2015/03/27 06:00
MHDA- 2015/09/12 06:00
PMCR- 2016/12/01
CRDT- 2015/03/27 06:00
PHST- 2014/11/12 00:00 [received]
PHST- 2015/01/30 00:00 [accepted]
PHST- 2015/03/27 06:00 [entrez]
PHST- 2015/03/27 06:00 [pubmed]
PHST- 2015/09/12 06:00 [medline]
PHST- 2016/12/01 00:00 [pmc-release]
AID - PBC25501 [pii]
AID - 10.1002/pbc.25501 [doi]
PST - ppublish
SO  - Pediatr Blood Cancer. 2015 Aug;62(8):1305-16. doi: 10.1002/pbc.25501. Epub 2015 
      Mar 21.